WAT: Bernstein Reinstates Outperform
Bernstein analyst Eve Burstein reinstates Waters with an Outperform rating and $435 price target.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results.
Bernstein analyst Eve Burstein reinstates Waters with an Outperform rating and $435 price target.
Bernstein analyst Eve Burstein reinstates Guardant Health with an Outperform rating and $175 price target.
Bernstein reinstates Agilent Technologies with an Outperform rating and a $155 price target.